US Rep. Jerry McNerney (D-CA) last week filed an amendment to modify the House Agriculture appropriations bill to include critical funds that would enable FDA to undertake the appropriate processes and set a safe level of CBD.
Editor's Spotlight: Notes from Nutrition 2019 in Baltimore, June 8-11
Is there a role for cannabis and its derivatives to play in our food system, perhaps as part of a healthy, well-balanced diet? Scientists explored the question at the recent Nutrition 2019 conference in Baltimore.
Lessons learned from the history of the dietary supplement industry can be applied to the hemp world, and the blitzkrieg-like pace of the industry means we’ll know in short order who’s getting the message and who isn’t. It will also put pressure on regulators...
Pet owners are more likely to support the legalization of marijuana than the overall population, according to a recent Packaged Facts survey. They’re also more likely to agree that both prescription and OTC hemp, CBD, and cannabis products should be legal.
Friday’s public meeting was an illuminating day of presentations, with multiple viewpoints and interests being aired. On the dietary supplements side, there were strong calls for companies to take the front door with the Agency.
Gaia Herbs, a leading brand of botanical supplements in terms of sales with distribution in national chains like CVS and Whole Foods Market, has started sales for its full spectrum hemp extract line on its website and will roll out across natural and...
Early returns from the FDA meeting on CBD regulation give a glimpse of the complexity of the regulatory questions, which might stretch the timeline for a new legal framework to extent beyond which many in the industry would find acceptable.
“If we do not succeed in working together to reassure the card brands that they can safely support our industry, then we predict a significant decrease in CBD sales within the next few months,” the National Cannabis Industry Association (NCIA) has warned.